Backend Engineer, Applied Agents (Los Altos)
Cheiron just raised an $8 million seed round led by Menlo Ventures to build the operating system for drug programs.
■ Company Overview
In July 2026, Cheiron announced an $8 million seed round led by Menlo Ventures, bringing total funding to $13 million to date, with the backing and strategic support of industry veterans including Moderna co-founder and MIT Institute Professor Robert Langer, former Pfizer Chief Medical Officer Freda Lewis-Hall, Chai Discovery co-founder and CEO Josh Meier, former Starbucks CEO Laxman Narasimhan, and former Apple AI chief John Giannandrea.
Cheiron is building the first AI-native operating system designed to represent an entire drug program as a single connected system. The company's platform helps biopharma teams represent, reason over, and stress-test the full state of a drug development program — including the claims, evidence, assumptions, risks, decisions, and commitments that determine whether a therapy advances.
At the center of the platform is Cheiron's proprietary Life Sciences Knowledge Graph (LKG), connecting the world's biomedical, clinical, regulatory, patent, and commercial knowledge into a single model built for the inferences dru
